Ara
Toplam kayıt 83, listelenen: 81-83
Overview of current pharmacotherapeutic options in benign prostatic hyperplasia
(Taylor and Francis Ltd., 2023)
Introduction: Benign prostatic hyperplasia (BPH) represents the histological entity of prostate cell proliferation, which inflicts a gradually increasing obstruction of the bladder outlet and is accompanied by a progressing ...
Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitude, and practice survey
(Elsevier (Singapore) Pte. Ltd., 2024)
Objective: To scrutinize the definitions of minimal invasive surgical therapy (MIST) and to investigate urologists' knowledge, attitudes, and practices for benign prostatic obstruction surgeries. Methods: A 36 -item survey ...
Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study
(Springer Science and Business Media Deutschland GmbH, 2024)
Purpose: Diagnostic ureteroscopy (dURS) is optional in the assessment of patients with upper tract urothelial carcinoma (UTUC) and provides the possibility of obtaining histology. Methods: To evaluate endoscopic biopsy ...